Cleared Abbreviated

K072296 - POIINT OF CARE STRANDING SYSTEM, MODE 1004-00

K072296 is an FDA 510(k) clearance for POIINT OF CARE STRANDING SYSTEM, manufactured by Theragenics Corp.. The device is a Class 2 Radiology device with product code KXK cleared through the Abbreviated 510(k) pathway after a 40-day FDA review.

K072296 · Theragenics Corp. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2007
Decision
40d
Days
Class 2
Risk

K072296 is an FDA 510(k) clearance for the POIINT OF CARE STRANDING SYSTEM, MODE 1004-00. Classified as Source, Brachytherapy, Radionuclide (product code KXK), Class II - Special Controls.

Submitted by Theragenics Corp. (Buford, US). The FDA issued a Cleared decision on September 26, 2007 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

FDA 510(k) Submission Details - K072296

510(k) Number K072296 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 2007
Decision Date September 26, 2007
Days to Decision 40 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 107d · This submission: 40d
Pathway characteristics
Standards-based clearance path.

KXK Device Classification - Class 2, Special Controls

Product Code KXK Source, Brachytherapy, Radionuclide
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KXK Source, Brachytherapy, Radionuclide

All 145
Devices cleared under the same product code (KXK) and FDA review panel - the closest regulatory comparables to K072296.
SPEC MODEL M-31
K090366 · Source Production & Equipment Co., Inc. · Apr 2009
WORLDWIDE MEDICAL TECHNOLOGIES ANCHOR MARKER, MARKER STRAND AND MARKER
K083274 · Biocompatibles, Inc. · Jan 2009
CIVASTRING PD-103
K082159 · Civatech Oncology, Inc. · Sep 2008
PRE-WAXED NEEDLES WITH GOLD FIDUCIARY MARKERS
K071550 · Cp Medical · Jul 2007
AOS MARKER SEEDS
K062825 · Alpha-Omega Services, Inc. · May 2007
IMPLANT SCIENCES CORP. MODEL HDR 4454
K070468 · Implant Sciences Corp. · Mar 2007
K072296 · POIINT OF CARE STRANDING SYSTEM, MODE 1004-00
Download PDF FDA Summary Theragenics Corp.